We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current TGRNF market cap is 541.69M. The company's latest EPS is CNY 0.9387 and P/E is 0.92.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Revenue | 4.48B | 4.61B | 5.4B | 5.99B | 6.77B |
| Operating Income | 936.8M | 965.39M | 1.07B | 1.21B | 1.13B |
| Net Income | 417.65M | 467.55M | 507.25M | 582.89M | 590.19M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Total Assets | 10.47B | 10.94B | 11.59B | 12.48B | 13.51B |
| Total Liabilities | 3.06B | 3.19B | 3.44B | 3.47B | 3.86B |
| Total Equity | 7.41B | 7.75B | 8.16B | 9.02B | 9.65B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CNY (元) | CNY (元) | CNY (元) | CNY (元) | CNY (元) | |
| Operating | 1.05B | 435.81M | 1.03B | 723.77M | 554.18M |
| Investing | 456.9M | -195.44M | -197.36M | 43.01M | -1.07B |
| Financing | -466.11M | -164.51M | -474.67M | -499.45M | -497.76M |
| Market Cap | 541.69M |
| Price to Earnings Ratio | 0.92 |
| Price to Sales Ratio | 0.08 |
| Price to Cash Ratio | 0.2 |
| Price to Book Ratio | 0.06 |
| Dividend Yield | - |
| Shares Outstanding | 628.7M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | 1.47% |
| 52 Week High | 0.8616 |
| 52 Week Low | 0.8491 |
| Spread (Intraday) | 0.08 (11.11%) |
| Company Name | Tong Ren Tang Technologies (PK) |
| Address |
no. 16 tongji beilu beijing |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
